NCM · Biotechnology

PULM (PULM) Stock

$1.65 -0.60% NCM: PULM Healthcare

Valuation

MetricValue
Price$1.65
Market Cap$6.03M
P/E Ratio-0.90
P/B Ratio1.16
P/S Ratio0.00
EPS (TTM)$-1.41
52-Week High$9.15
52-Week Low$1.16
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-125.00%
ROA-125.00%
ROCE-125.00%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.00
Current Ratio4.96

Annual Financials (USD)

Metric20212022202320242025
Revenue$5.0M$6.0M$7.0M$8.0M$0
Operating Profit$-20.0M$-19.0M$-15.0M$-10.0M$-5.0M
Net Profit$-20.0M$-19.0M$-14.0M$-10.0M$-5.0M
EPS$-8.63$-5.43$-3.87$-2.62$-1.41
Op Margin-390.1%-312.1%-202.0%-125.1%—

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$59.0M$41.0M$34.0M$10.0M$4.0M
Total Liabilities$11.0M$10.0M$16.0M$1.0M$0
Cash$54.0M$36.0M$19.0M$10.0M$4.0M
Borrowings$2.0M$1.0M$9.0M$0$0

Latest News

Pulmatrix Announces First Quarter 2026 Financial Results PR Newswire · May 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-20.0M$-19.0M$-16.0M$-11.0M$-5.0M
Investing Cash Flow$0$0$-1.0M$-1.0M$0
Financing Cash Flow$3.0M$0$0$0$0
Net Cash Flow$24.0M$-18.0M$-17.0M$-11.0M$-5.0M
Free Cash Flow$-20.0M$-19.0M$-17.0M$-11.0M$-5.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-101.05%
Quick Ratio4.96
Interest Coverage—
Return 1Y-74.51%
Return 3Y-42.07%
Return 5Y-90.60%

Ownership

Insiders Held0.77%
Institutions Held9.02%
Institutions Float Held9.09%
Institutional HolderSharesReport Date
Renaissance Technologies, LLC109,1482026-03-31
Blackrock Inc.54,8992026-03-31
Geode Capital Management, LLC44,6292026-03-31
Vanguard Capital Management LLC33,5942026-03-31
SBI Securities Co., Ltd.30,0852026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADTX $0.01 -77.22% -0.01 $318 0.00%
ASBP $7.26 +3.13% -0.74 $837601 0.00%
CRIS $4.69 -4.09% -0.35 $9.14M 0.00%
CTXR $0.57 -9.81% -0.68 $6.37M 0.00%
DARE $1.32 +3.13% -1.94 $12.57M 0.00%

About PULM

PULM is led by CEO Peter Ludlum, employs 2 people, headquartered in US, publicly traded since 2014.

PULM stock trades at $1.65 with a market capitalization of $6.03M. The stock is valued at a price-to-earnings (P/E) ratio of -0.90, price-to-book of 1.16, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $1.16 and $9.15, and currently trades 82.0% below its 52-week high.

On profitability, PULM generates a return on equity (ROE) of -125.00%, return on capital employed of -125.00%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides